Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. CEO Pascal Soriot is ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the UK. AstraZeneca stock is inching down following the exit news today.

Words by Isabel O’Brien AstraZeneca has claimed the top spot as the most attractive pharmaceutical company to work for among UK natural sciences students in 2025, according to the latest Universum ...

Land of opportunity Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market ...

FDA under fire: Data discrepancies uncovered in AstraZeneca approval trials Investigation finds evidence of serious misreporting, raising fresh doubts over the approval and decade long use of ...